Recent News

• 06.25.2025 - Hepion Pharmaceuticals Successfully Completes Application to the OTCQB
• 06.16.2025 - Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer
• 05.12.2025 - Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

Recent Filings

• 06.12.2025 - 8-K Current report
• 06.09.2025 - 8-K Current report
• 05.30.2025 - 8-K Current report
• 05.19.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2025 - NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.12.2025 - 8-K Current report
• 05.12.2025 - EX-99.1 EX-99.1
• 05.06.2025 - 8-K Current report
• 04.29.2025 - ARS Annual Report to Security Holders